We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Relationship Between Dopamine Genetics, Food Reinforcement, Energy Intake and Obesity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00962117
Recruitment Status : Completed
First Posted : August 19, 2009
Last Update Posted : June 13, 2012
Sponsor:
Information provided by (Responsible Party):
Leonard Epstein, State University of New York at Buffalo

Brief Summary:
The purpose of the study is to determine whether the presentation of various foods produces an increase or decrease in responses on a motivational computer task. In addition, the study determines if energy intake or motivation to obtain food is related to the dopamine receptor genotype.

Condition or disease
Obesity

Detailed Description:
One of the most important research areas in obesity is developing a better understanding of individual differences in factors that influence excess energy intake and positive energy balance. One key to understanding these individual differences is determining what factors underlie the motivation to eat. We have demonstrated in a series of studies that obese adults and children are more motivated to work for palatable, favorite foods than leaner peers and that those high in food reinforcement consume more food in an ad libitum eating task than those who do not find food as reinforcing. Dopamine (DA) is one of the major neurotransmitters involved in establishing the reinforcing value of food, and low levels of dopamine activity and a reduction in the number of DA receptors is associated with obesity. The general aim of the proposed research is to build upon this research to examine relationships between food reinforcement, obesity, and polymorphisms of genes within the dopaminergic system.

Study Type : Observational
Actual Enrollment : 310 participants
Time Perspective: Cross-Sectional
Official Title: Food Reinforcement Genotype Interactions and Eating
Study Start Date : February 2008
Primary Completion Date : June 2011
Study Completion Date : June 2011

Resource links provided by the National Library of Medicine

Drug Information available for: Dopamine
U.S. FDA Resources

Group/Cohort
Obese/Non-obese



Biospecimen Retention:   Samples With DNA
Saliva DNA samples will be collected from all participants


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Subjects will be recruited from newspaper ads, posters on campus and in community settings, web based recruitment (ads on Craig's list and on the department's website) and direct mail targeted to community residents between 18-50 years of age.
Criteria

Inclusion Criteria:

  • Non-smokers
  • 18-50 years of age
  • No known eating disorder
  • Moderate liking for study foods
  • No current diagnosis of psychiatric disorder (e.g., anxiety or depression)
  • Not on medications that would interfere with appetite (e.g., methylphenidate) or dopaminergic activity
  • Non-diabetics

Exclusion Criteria:

  • Smoker
  • Pregnant women
  • Current diagnosis of a psychiatric or eating disorder
  • Dietary restrictions that would interfere with participation
  • On medications that could interfere with appetite or olfactory responsiveness or use of antidepressants or any medication or dietary supplement that could affect appetite or dopaminergic activity
  • Excessive use of alcohol (>21 drinks/week), alcoholism,current addiction to opiates, cocaine or stimulants

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00962117


Sponsors and Collaborators
State University of New York at Buffalo
Investigators
Principal Investigator: Leonard H Epstein, Ph.D. SUNY Buffalo

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Leonard Epstein, SUNY Distinguished Professor of Pediatrics and Social and Preventive Medicine, State University of New York at Buffalo
ClinicalTrials.gov Identifier: NCT00962117     History of Changes
Other Study ID Numbers: 1066937
1066937-1-44786
First Posted: August 19, 2009    Key Record Dates
Last Update Posted: June 13, 2012
Last Verified: June 2012

Keywords provided by Leonard Epstein, State University of New York at Buffalo:
Food Reinforcement
Energy Intake
Obesity
Dopamine

Additional relevant MeSH terms:
Obesity
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms
Dopamine
Cardiotonic Agents
Sympathomimetics
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Dopamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Protective Agents